AU4933000A - Hydroxamic and carboxylic acid derivatives - Google Patents

Hydroxamic and carboxylic acid derivatives

Info

Publication number
AU4933000A
AU4933000A AU49330/00A AU4933000A AU4933000A AU 4933000 A AU4933000 A AU 4933000A AU 49330/00 A AU49330/00 A AU 49330/00A AU 4933000 A AU4933000 A AU 4933000A AU 4933000 A AU4933000 A AU 4933000A
Authority
AU
Australia
Prior art keywords
hydroxamic
carboxylic acid
acid derivatives
derivatives
carboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49330/00A
Inventor
Duncan Batty
Andrew Douglas Baxter
Duncan Hannah
David Alan Owen
Robert John Watson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darwin Discovery Ltd
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of AU4933000A publication Critical patent/AU4933000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU49330/00A 1999-05-12 2000-05-12 Hydroxamic and carboxylic acid derivatives Abandoned AU4933000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9911071.0A GB9911071D0 (en) 1999-05-12 1999-05-12 Hydroxamic and carboxylic acid derivatives
GB9911071 1999-05-12
PCT/GB2000/001810 WO2000069827A1 (en) 1999-05-12 2000-05-12 Hydroxamic and carboxylic acid derivatives

Publications (1)

Publication Number Publication Date
AU4933000A true AU4933000A (en) 2000-12-05

Family

ID=10853354

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49330/00A Abandoned AU4933000A (en) 1999-05-12 2000-05-12 Hydroxamic and carboxylic acid derivatives

Country Status (3)

Country Link
AU (1) AU4933000A (en)
GB (1) GB9911071D0 (en)
WO (1) WO2000069827A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794385B2 (en) 2001-08-08 2004-09-21 Pharmacia & Upjohn, S.P.A. Benzoxazine derivatives useful as integrin receptor antagonists
MXPA04010240A (en) 2002-04-17 2005-06-08 Cytokinetics Inc Compounds, compositions, and methods.
DE60326248D1 (en) 2002-07-17 2009-04-02 Cytokinetics Inc Compounds, compositions and methods for treating cellular proliferative disorders
US7652036B2 (en) 2003-02-25 2010-01-26 Topotarget Uk Limited Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
US20210393632A1 (en) 2018-10-04 2021-12-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Egfr inhibitors for treating keratodermas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2218092B1 (en) * 1973-02-19 1976-03-05 Delalande Sa Fr
FR2338041A1 (en) * 1976-01-16 1977-08-12 Delalande Sa Antibronchoconstricting furo benzoxazol acethydroxamic acids prepn. - by treating the corresp. ethyl ester with hydroxyl amine
GB1574822A (en) * 1976-03-23 1980-09-10 Lafon Labor Acetohydroxamic acid derivatives and pharmaceutical compositions thereof
DE69737605T2 (en) * 1996-01-23 2008-04-03 Shionogi & Co., Ltd. Sulphonated Amino Acid Derivatives and Metalloproteinase Inhibitors Containing Them
ATE210637T1 (en) * 1996-10-16 2001-12-15 American Cyanamid Co PREPARATION AND APPLICATION OF ORTHO-SULFONAMIDO-ARYL-HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS

Also Published As

Publication number Publication date
GB9911071D0 (en) 1999-07-14
WO2000069827A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
AU3312100A (en) Hydroxamic and carboxylic acid derivatives
EP1216980A4 (en) Carboxylic acid derivatives and drugs containing the same
IL145732A0 (en) α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
AU5652001A (en) Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
HUP0100597A3 (en) Hydroxamic and carboxylic acid derivatives
IL147216A0 (en) Arylsulfonamido-substituted hydroxamic acid derivatives
AU7940598A (en) Quinolone carboxylic acid derivatives
AU1303201A (en) Alkoxyiminoalkanoic acid derivatives
GB9929979D0 (en) Hydroxamic acid derivatives
AU4933000A (en) Hydroxamic and carboxylic acid derivatives
AU5499401A (en) Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
AU4596300A (en) Hydroxamic and carboxylic acid derivatives
AU4595800A (en) Hydroxamic and carboxylic acid derivatives
AU7608100A (en) 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1-carboxylates as neuraminidase inhibitors
AU6866700A (en) Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof
HUP0102073A3 (en) Hydroxamic and carboxylic acid derivatives and medicaments containing them
AU1812197A (en) Hydroxamic acid derivatives
AU5974100A (en) 6-carboxyphenyldihydropyridazinone derivatives and use thereof
GB9911072D0 (en) Hydroxamic and carboxylic acid derivatives
GB9906585D0 (en) Hydroxamic and carboxylic acid derivatives
GB9927782D0 (en) Hydroxamic and carboxylic acid derivatives
GB9906581D0 (en) Hydroxamic and carboxylic acid derivatives
IL148669A0 (en) 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof
AU6150400A (en) Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof
GB9813932D0 (en) Hydroxamic and carboxylic acid derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase